TOP DEOXYSHIKONIN SECRETS

 one prior program of chemotherapy for Highly developed breast cancer and across the whole trial, preceding exposure to any FGFR inhibitor, significant operation or radiotherapy inside 4 months previous to initially dose of study therapy and having strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the subsequent cardiac conditions preclud